- Home
- BLNK vs CADL Comparison
BLNK vs CADL Comparison
Compare BLNK & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- CADL
- Stock Information
- Founded
- BLNK 2009
- CADL 1999
- Country
- BLNK United States
- CADL United States
- Employees
- BLNK N/A
- CADL N/A
- Industry
- BLNK Industrial Specialties
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- BLNK Consumer Discretionary
- CADL Health Care
- Exchange
- BLNK Nasdaq
- CADL Nasdaq
- Market Cap
- BLNK 163.4M
- CADL 159.1M
- IPO Year
- BLNK N/A
- CADL 2021
- Fundamental
- Price
- BLNK $1.39
- CADL $6.61
- Analyst Decision
- BLNK Buy
- CADL Strong Buy
- Analyst Count
- BLNK 7
- CADL 1
- Target Price
- BLNK $5.92
- CADL $19.00
- AVG Volume (30 Days)
- BLNK 4.7M
- CADL 2.4M
- Earning Date
- BLNK 03-13-2025
- CADL 11-14-2024
- Dividend Yield
- BLNK N/A
- CADL N/A
- EPS Growth
- BLNK N/A
- CADL N/A
- EPS
- BLNK N/A
- CADL N/A
- Revenue
- BLNK $138,728,000.00
- CADL N/A
- Revenue This Year
- BLNK N/A
- CADL N/A
- Revenue Next Year
- BLNK $22.16
- CADL N/A
- P/E Ratio
- BLNK N/A
- CADL N/A
- Revenue Growth
- BLNK 15.13
- CADL N/A
- 52 Week Low
- BLNK $1.31
- CADL $1.16
- 52 Week High
- BLNK $3.75
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- BLNK 38.51
- CADL 43.00
- Support Level
- BLNK $1.41
- CADL $6.83
- Resistance Level
- BLNK $1.51
- CADL $8.08
- Average True Range (ATR)
- BLNK 0.11
- CADL 0.79
- MACD
- BLNK -0.01
- CADL -0.34
- Stochastic Oscillator
- BLNK 15.69
- CADL 5.25
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.